Finance

Beta
Lists
GRDN:NYSE
Guardian Pharmacy Services Inc
$42.41
-2.28%
(-0.99) 1D
$42.41
0.00% (0.00)
After hours
Closed: Jun 18, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GRDN...
Open
$43.90
High
$44.00
Low
$42.12
Mkt. cap
2.69B
Avg. vol.
409.24K
Volume
1.00M
P/E ratio
51.59
52-wk high
$44.00
52-wk low
$19.30
EPS
$0.82
Shares outstanding
49.78M
No. of employees
4K
Open
$43.90
High
$44.00
Low
$42.12
Mkt. cap
2.69B
Avg. vol.
409.24K
Volume
1.00M
P/E ratio
51.59
52-wk high
$44.00
52-wk low
$19.30
EPS
$0.82
Shares outstanding
49.78M
No. of employees
4K
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to GRDN in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for GRDN in the last 3 months.
Highest
Current $42.41
$50.00 (+17.90%)
Average
$46.75 (+10.23%)
Lowest
$43.00 (+1.39%)
News stories
From sources across the web
About Guardian Pharmacy Services Inc
CEO-
Employees3.6K
Founded2003
HeadquartersAtlanta, Georgia, United States
SectorHealth care provider
Websiteguardianpharmacy.com
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.29 / $0.24
+20.83%beat
Revenue / Est. (USD)
336.60M / 329.13M
+2.27%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
344.33M
377.43M
397.62M
336.60M
Cost of goods sold
276.19M
302.71M
312.11M
260.29M
Cost of revenue
276.19M
302.71M
312.11M
260.29M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53.07M
57.82M
50.14M
55.43M
Operating expense
53.07M
57.82M
50.14M
55.43M
Total operating expenses
329.26M
360.53M
362.25M
315.72M
Operating income
15.08M
16.90M
35.37M
20.88M
Other non operating income
179.00K
437.00K
500.00K
772.00K
EBT including unusual items
12.59M
16.63M
31.10M
18.29M
EBT excluding unusual items
15.08M
17.18M
35.70M
21.50M
Income tax expense
3.76M
7.04M
9.83M
4.75M
Effective tax rate
29.87%
42.32%
31.62%
25.96%
Other operating expenses
-
-
-
-
Net income
9.03M
9.82M
20.92M
13.30M
Net profit margin
2.62%
2.60%
5.26%
3.95%
Earnings per share
0.22
0.25
0.37
0.29
Interest and investment income
-
-
-
-
Interest expense
-172.00K
-160.00K
-163.00K
-154.00K
Net interest expenses
-172.00K
-160.00K
-163.00K
-154.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
20.57M
22.74M
41.11M
26.85M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer